Star Imaging & Path Lab IPO Subscription Status

BSE SME
Minimum investment
₹ 2,84,000 2000 shares
View IPO details

Data sourced from BSE · Compiled by IPO Ji · IPO subscription data last updated

Total 0.44x·QIB 0.00x·NII 1.12x·Individual 0.41x

Star Imaging & Path Lab Limited SME IPO was subscribed 0.44x in total when bidding closed on Aug 12, 2025, with 0x in the QIB category, 1.12x in NII, 0.41x in individual across BSE. The issue closed undersubscribed, with applications falling short of the shares on offer. The issue ran from Aug 8, 2025 to Aug 12, 2025 at a price band of ₹135–₹142 per share. Allotment was finalised on Aug 13, 2025.

QIB0.00xNII1.12xIndividual0.41xTotal0.44x1x
Times subscribed by category against the 1× fully-subscribed line (bars capped at 10×).
Advertisement
Advertisement

Subscription Details (No. of Shares)

Category Offer Applied Times
QIBs 871000 0 0
NIIs 657000 733000 1.12
BNIIs (>10L) 438000 639000 1.46
SNIIs (<10L) 219000 94000 0.43
Individual 1528000 620000 0.41
Employee 52000 5000 0.1
Total 3108000 1358000 0.44
Total Applications365 approx.

Application Wise Breakup (Approx.)

Category Reserve Applied Times
Total Applications365 approx.

Subscription Details (In Crores)

Category Offered Demand Times
QIBs 12.37 0 0
NIIs 9.33 10.41 1.12
BNIIs (>10L) 6.22 9.07 1.46
SNIIs (<10L) 3.11 1.33 0.43
Individual 21.7 8.8 0.41
Employee 0.74 0.07 0.1
TOTAL 44.13 19.28 0.44

Day-wise subscription

Total subscription trend0.05x to 5.67x+5.62x
0.00x5.67x1x0.05xDay 10.28xDay 25.67xDay 3
As on QIB Individual Total
Day 1
8 Aug 2025
6:00 PM
0.13x 0.05x 0.05x
Day 2
11 Aug 2025
6:00 PM
0.39x 0.41x 0.28x
Day 3
12 Aug 2025
6:00 PM
4.38x 2.32x 5.67x

Subscription by number of applications

Anticipated subscription based on the number of applications received (an alternative to the shares-based figures above), sourced from BSE.

CategoryTimes (by applications)
QIB0.00x
bHNI0.00x
sHNI0.00x
Individual0.00x
Employee0.00x
Total applications~365

What this means for allotment & listing

As the issue closed below 1x, applicants who bid had a higher chance of receiving a full allotment, subject to the issue having achieved its minimum subscription. In oversubscribed issues, shares are allotted according to the applicable category and exchange rules, so applicants are not guaranteed full allotment once an issue is oversubscribed. The number of times each category is subscribed is one indicator of demand, alongside the company's fundamentals and the broader market.

A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice. Investors should read the company's prospectus and consult a SEBI-registered adviser before making any decision.

Listed at BSE SME · Registrar: Kfin Technologies Limited · Bidding data sourced from the BSE public-issue platform under SEBI ICDR regulations.

IPO subscription status shows how many times an issue has been applied for, compared with the shares on offer, broken down by Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and the Retail or SME Individual Investor category. A figure of "2x" means investors applied for twice the shares available. See how IPO subscription works and track all live IPOs →

Star Imaging & Path Lab IPO subscription FAQs

Star Imaging & Path Lab Limited IPO was subscribed 0.44x at close on Aug 12, 2025, with 0x in QIB, 1.12x in NII, 0.41x in individual.

Not yet. Star Imaging & Path Lab IPO was subscribed 0.44x, which is below 1x. Subscription often rises on the final day of bidding.

The Star Imaging & Path Lab IPO allotment was finalised on Aug 13, 2025. You can check your allotment status by PAN or application number on the registrar's website or on IPO Ji.

Star Imaging & Path Lab IPO has a price band of ₹135–₹142 per share, with a minimum individual investor application of ₹2,84,000 for 2000 shares.

It means investors have applied for X times the number of shares the company is offering. For example, 5x means demand was five times the shares available. A figure above 1x is called oversubscription; below 1x is undersubscription.

No. The higher an issue is oversubscribed, the lower each applicant’s chance of allotment. SME shares are allotted according to the applicable Individual Investor, NII and exchange rules, so oversubscription does not guarantee full allotment.

QIB covers qualified institutions. Under the current SME IPO framework, an Individual Investor applies for the minimum application size of two lots above ₹2 lakh, while applicants bidding for more than two lots are classified in the NII category. Each category has its own reserved portion and allotment rules.

IPO Ji updates subscription figures through the bidding day using data sourced from BSE. The "Last updated" time shown on the page reflects the most recent refresh.

Other live IPO subscriptions

Advertisement
Important Disclaimer

Data Source: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites.

Purpose: The information / data provided herein is for informational purposes only and is provided by ipoji.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied.

Accuracy: ipoji.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites.

Liability: ipoji.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. ipoji.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites.

User Responsibility: The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.